The first stop for professional medicines advice

Medicine

318 results

Applied filters

Preparing to use denosumab 60mg biosimilar for osteoporosis

11 August 2025Biosimilars of denosumab (Prolia) are expected soon. We offer general information and implementation advice.

Preparing to use denosumab 120mg biosimilar

11 August 2025Biosimilars of denosumab 120mg (Xgeva) are expected soon. We offer general information and implementation advice.

Cytarabine: informing intrathecal risk assessment

5 August 2025Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin: informing intrathecal risk assessment

5 August 2025Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Compatibility of nebuliser solution combinations

16 July 2025Guidance on what to consider when mixing nebuliser solutions and advice on which combinations are compatible.

Using antipsychotics during breastfeeding

14 July 2025Quetiapine is the preferred second-generation, and haloperidol the preferred first-generation antipsychotic when breastfeeding full term, healthy infants.

Cutting or masking transdermal patches safely

9 July 2025Cutting or masking transdermal patches is discouraged. Matrix patches can be cut if no licensed alternatives are available; reservoir patches should not be cut.

Managing problems when using transdermal patches

9 July 2025Guidance on adhesion, skin reactions, missing, omitted or delayed application, dosing intervals, switching, accidental exposure, and MRI scan considerations.

Using transdermal patches safely in healthcare settings

9 July 2025Practical guidance for safe application, monitoring, removal, disposal, documentation and storage of transdermal patches to reduce risk of medication errors.

Hydromorphone: informing intrathecal risk assessment

8 July 2025Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration